Finding:
Freebase
searching
Factz
searching
Articles
searching
Celltech
freebase
| UCB (Union chimique belge; Euronext: UCB), is a biopharmaceutical manufacturer headquartered in Brussels (Belgium). UCB was founded in 1928 by Emmanuel Janssen, a Belgian businessman. Initially focused on industrial chemicals, the company also included a small pharmaceutical division based... Read enhanced Wikipedia article |
|
-
close
Celltech
Celltech Group plc was a leading British-based biotechnology business based in Slough. It was listed on the London Stock Exchange and was a constituent of the FTSE 100 Index. -
close
List of pharmaceutical manufacturers in the United Kingdom
This is a list of manufacturers and suppliers of pharmaceuticals with operations in the United Kingdom. ... Celltech – UCB Pharma Ltd -
close
Chiroscience
Chiroscience Group Plc was a British-based biotech company, founded by Christopher Evans. The company was taken over by Celltech, which was acquired in 2004 by UCB. -
close
Cambridge Antibody Technology
Cambridge Antibody Technology, or CAT, was the UK biotechnology group of companies whose success was based mainly on its ability to generate antibody therapeutics, primarily using phage display, and the subsequently acquired ribosome display, technology. ... Celltech completed the purchase of OGS in April 2003. -
close
FTSE 100 Index
The FTSE 100 Index — also called FTSE 100, FTSE, or, informally, the "footsie" (pronounced /ˈfʊtsiː/) — is a share index of the 100 most highly capitalised UK companies listed on the London Stock Exchange. ... Celltech (acquired by UCB in 2004) -
close
UCB (company)
UCB (Union chimique belge; Euronext: UCB), is a biopharmaceutical manufacturer headquartered in Brussels (Belgium). ... By divesting all of its non-pharmaceutical activities, and acquiring Celltech, UCB has transformed itself into a global biopharmaceutical company. -
close
MedImmune, Inc. v. Genentech, Inc.
MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007) was a decision by the Supreme Court of the United States involving patent law. ... The origin of the dispute was a lengthy interference proceeding between Genentech and Celltech which led to the issuance of a new patent in 2001, 18 years after the original filing. -
close
Mark Dodgson
Mark Dodgson (born 1 May 1957) is a Australian academic and author. ... He conducted one of the first comprehensive studies of the emerging phenomenon of biotechnology firms by writing the history of the UK’s pioneering company, Celltech. -
close
Alan Munro
Alan James Munro (born 19 February 1937) is a British immunologist and entrepreneur. ... In 1988, Munro spent a sabbatical year working in the biotechnology company Celltech. -
close
Cabilly patents
The Cabilly patents are two US patents issued to Genentech which relate to the "fundamental technology required for the artificial synthesis of antibody molecules".[citation needed] The name refers to the lead inventor Shmuel Cabilly. ... An interference between U.S. Patent 4,816,567 (the original "Cabilly patent") issued to Genentech and U.S. Patent 4,816,397 (the "Boss" patent) issued to Celltech resulted in the issuance of a second "Cabilly patent" to Genentech in 2001.
Explore the following pages on Powerset:
quillback_wikipedia_9.20100317:parse:serp:Celltech
Celltech